Category: Regulations
-
Report: More Biotech Regulations Needed, and Soon
A new report from the National Academies calls for a more robust and responsive regulatory system to handle an anticipated flood of biotechnology products.
-
Trial Shows Bioactive Glass Stops Bone Infections
Grafts of glass-based substitute material were shown in a clinical trial to stop bacterial bone infections from osteomyelitis, in most cases without additional antibiotics.
-
Trial Underway to Test Cancer Immunotherapy Aid
A clinical trial began recruiting participants with advanced tumors to test a compound that helps treatments for cancer harnessing the immune system.
-
Mobile App-Controlled Patch Reduces Migraine Pain
A patch worn on the arm providing stimulation to nerve cells was shown in a clinical trial to reduce the amount of pain experienced by people with migraines.
-
Engineered T-Cells Shown Reducing Non-Hodgkin Lymphoma
A clinical trial testing synthetic immune system cells shows after 6 months the cells can generate a full or partial response in many patients with non-Hodgkin lymphoma.
-
Trial Begins Testing Enhanced Cord Blood Stem Cells
A clinical trial testing transplant grafts derived from umbilical cord blood as an alternative to bone marrow stem cells for people with blood-related cancers is treating its first patient.
-
Public Access to Drugs Meets Health Needs, Cuts Costs
A study shows adding universal access to essential drugs as part of Canada’s health care system would meet much of that country’s pharmaceutical needs and save billions of dollars.
-
Biofeedback Device Reduces Panic Attacks in Trial
A medical device that provides people with panic disorder feedback on their abnormal breathing is shown in a clinical trial to reduce panic severity 12 months after treatment.
-
Online Pharmacies Seen Fueling Antibiotic Overuse
A study of pharmacies selling drugs online shows many of these sites offer antibiotics to consumers in the U.K. without prescriptions, which would be illegal in retail drug stores.
-
Biotech Group Withholds Support for Germline Trial Report
A biotechnology industry association in the U.S. says its members are not ready to support recommendations in a new report permitting future clinical studies of genome editing for inheritable disease-causing traits.